Skip to content

Transcutaneous Auricular Vagus Nerve Stimulation to Reduce Myocardial Injury After Coronary Artery Bypass Grafting With Cardiopulmonary Bypass: A Randomized, Double-Blind Pilot Trial

Transcutaneous Auricular Vagus Nerve Stimulation to Reduce Myocardial Injury After Coronary Artery Bypass Grafting With Cardiopulmonary Bypass: A Randomized, Double-Blind Pilot Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500113341
Enrollment
Unknown
Registered
2025-11-27
Start date
2025-11-28
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myocardial injury

Interventions

Active taVNS Group:Participants in the ta-VNS group underwent stimulation of the left cymba conchae. Stimulation parameters were set as follows: frequency 25 Hz, pulse width 250 µs, with a duty cycle
Sham taVNS Group:Participants in the sham stimulation group followed the same intervention protocol as the ta-VNS group
however, the electrical stimulation device was turned off after the intensity adjustment procedure. All devices were labeled to ensure that each participant used the same device for every session. Par

Sponsors

Nanjing First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Age>=40 and <=85 years; 2. ASA classification I–III; 3. Planned isolated selective coronary artery bypass grafting (CABG) under CPB with general anesthesia; 4. NYHA cardiac function classification I–III; 5. Voluntarily participating in this study and signing the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Emergency coronary artery bypass graft surgery; 2. Left ventricular ejection fraction (LVEF) 0.3 µg/kg/min); 8. Recent cerebrovascular accident (< 6 months); 9. Seizure or syncope recurrence in the past 5 years; 10. Patients who received vagus nerve stimulation or acupuncture treatment within 1 month before the study.

Design outcomes

Primary

MeasureTime frame
cTn level at 24 hours postoperatively;

Secondary

MeasureTime frame
Immediate postoperative cTn level;cTn level at 72 hours postoperatively;Postoperative NT-proBNP levels;Creatine kinase-MB (CK-MB);Inflammatory markers;

Countries

China

Contacts

Public ContactYali Ge

Nanjing First Hospital

ge_yl@163.com+86 139 5209 1009

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026